Advanced systems biology methods in drug discovery and translational biomedicine

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Zou, Jun ^a   Zheng, Ming Wu ^a   Li, Gen ^a   Su, Zhi Guang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NEW DRUG; TRANSCRIPTOME;

ADVERSE DRUG REACTION; BINDING AFFINITY; BIOMEDICINE; CELL CYCLE; CELL FUNCTION; DISEASE COURSE; DNA DAMAGE; DRUG COMBINATION; DRUG DEVELOPMENT; DRUG INTERACTION; DRUG MECHANISM; DRUG REPOSITIONING; DRUG TARGETING; GENE EXPRESSION; GENE INTERACTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; INTRACELLULAR SPACE; KINETICS; MOLECULAR INTERACTION; NEGATIVE FEEDBACK; PHARMACOLOGY; PREDICTION; PROTEIN PROTEIN INTERACTION; REVIEW; SYSTEMS BIOLOGY; TRANSCRIPTION INITIATION; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE; ANIMAL; HUMAN; METHODOLOGY;

ANIMALS; DRUG DISCOVERY; HUMANS; SYSTEMS BIOLOGY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84885612492     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/742835     Document Type: Review

References (72)

1. Chuang H.-Y., Hofree M., Ideker T., A decade of systems biology. Annual Review of Cell and Developmental Biology 2010 26 721 744 2-s2.0-78049413383 10.1146/annurev-cellbio-100109-104122
2. Barabási A.-L., Gulbahce N., Loscalzo J., Network medicine: a network-based approach to human disease. Nature Reviews Genetics 2011 12 1 56 68 2-s2.0-78650373804 10.1038/nrg2918
3. Araujo R. P., Liotta L. A., Petricoin E. F., Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Nature Reviews Drug Discovery 2007 6 11 871 880 2-s2.0-35748935235 10.1038/nrd2381 (Pubitemid 350042395)
4. Pujol A., Mosca R., Farrés J., Aloy P., Unveiling the role of network and systems biology in drug discovery. Trends in Pharmacological Sciences 2010 31 3 115 123 2-s2.0-77649182705 10.1016/j.tips.2009.11.006
5. Sobie E. A., Lee Y.-S., Jenkins S. L., Iyengar R., Systems biology-biomedical modeling. Science Signaling 2011 4 190, article tr2 2-s2.0-84855562712
6. Faratian D., Clyde R. G., Crawford J. W., Harrison D. J., Systems pathology-taking molecular pathology into a new dimension. Nature Reviews Clinical Oncology 2009 6 8 455 464 2-s2.0-70350005352 10.1038/nrclinonc.2009.102
7. Ma'ayan A., Introduction to network analysis in systems biology. Science Signaling 2011 4 190, article tr5 2-s2.0-80052947609 10.1126/scisignal.2001965
8. Vidal M., Cusick M. E., Barabási A.-L., Interactome networks and human disease. Cell 2011 144 6 986 998 2-s2.0-79952674000 10.1016/j.cell.2011. 02.016
9. Chang X., Xu T., Li Y., Wang K., Dynamic modular architecture of protein-protein interaction networks beyond the dichotomy of "date" and "party" hubs. Scientific Reports 2013 3, article 1691
10. Aldridge B. B., Burke J. M., Lauffenburger D. A., Sorger P. K., Physicochemical modelling of cell signalling pathways. Nature Cell Biology 2006 8 11 1195 1203 2-s2.0-33750533388 10.1038/ncb1497 (Pubitemid 44660581)
11. Sobie E. A., An introduction to dynamical systems. Science Signaling 2011 4 191, article tr6 2-s2.0-80053096839 10.1126/scisignal.2001982
12. Neves S. R., Developing models in virtual cell. Science Signaling 2011 4 192, article tr12 2-s2.0-80053234250 10.1126/scisignal.2001970
13. Neves S. R., Obtaining and estimating kinetic parameters from the literature. Science Signaling 2011 4 191, article tr8 2-s2.0-80053122204 10.1126/scisignal.2001988
14. Costa K. D., Kleinstein S. H., Hershberg U., Biomedical model fitting and error analysis. Science Signaling 2011 4 192, article tr9 2-s2.0-80053266761 10.1126/scisignal.2001983
15. Fisher J., Henzinger T. A., Executable cell biology. Nature Biotechnology 2007 25 11 1239 1249 2-s2.0-36049044199 10.1038/nbt1356 (Pubitemid 350089829)
16. Zhang R., Shah M. V., Yang J., Nyland S. B., Liu X., Yun J. K., Albert R., Loughran T. P. Jr., Network model of survival signaling in large granular lymphocyte leukemia. Proceedings of the National Academy of Sciences of the United States of America 2008 105 42 16308 16313 2-s2.0-55849100058 10.1073/pnas.0806447105
17. Saez-Rodriguez J., Alexopoulos L. G., Epperlein J., Samaga R., Lauffenburger D. A., Klamt S., Sorger P. K., Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Molecular Systems Biology 2009 5, article 331 2-s2.0-71449120701 10.1038/msb.2009.87
18. Materi W., Wishart D. S., Computational systems biology in drug discovery and development: methods and applications. Drug Discovery Today 2007 12 7-8 295 303 2-s2.0-33947507091 10.1016/j.drudis.2007.02.013 (Pubitemid 46467486)
19. Goh K.-I., Cusick M. E., Valle D., Childs B., Vidal M., Barabási A.-L., The human disease network. Proceedings of the National Academy of Sciences of the United States of America 2007 104 21 8685 8690 2-s2.0-34547140875 10.1073/pnas.0701361104 (Pubitemid 47175372)
20. Linghu B., Snitkin E. S., Hu Z., Xia Y., DeLisi C., Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network. Genome Biology 2009 10 9, article R91 2-s2.0-76249105279 10.1186/gb-2009-10-9-r91
21. Suthram S., Dudley J. T., Chiang A. P., Chen R., Hastie T. J., Butte A. J., Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Computational Biology 2010 6 2 2-s2.0-77649222972 10.1371/journal.pcbi.1000662 e1000662
22. Wu G., Feng X., Stein L., A human functional protein interaction network and its application to cancer data analysis. Genome Biology 2010 11 5, article R53 2-s2.0-77952310528 10.1186/gb-2010-11-5-r53
23. Hwang D., Lee I. Y., Yoo H., Gehlenborg N., Cho J.-H., Petritis B., Baxter D., Pitstick R., Young R., Spicer D., Price N. D., Hohmann J. G., DeArmond S. J., Carlson G. A., Hood L. E., A systems approach to prion disease. Molecular Systems Biology 2009 5, article 252 2-s2.0-63149151206 10.1038/msb.2009.10
24. Yosef N., Shalek A. K., Gaublomme J. T., Dynamic regulatory network controlling TH17 cell differentiation. Nature 2013 496 7446 461 468
25. Arnit I., Garber M., Chevrier N., Leite A. P., Donner Y., Eisenhaure T., Guttman M., Grenier J. K., Li W., Zuk O., Schubert L. A., Birditt B., Shay T., Goren A., Zhang X., Smith Z., Deering R., McDonald R. C., Cabili M., Bernstein B. E., Rinn J. L., Meissner A., Root D. E., Hacohen N. H. A., Regev A., Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 2009 326 5950 257 263 2-s2.0-70349882120 10.1126/science. 1179050
26. Chuang H.-Y., Lee E., Liu Y.-T., Lee D., Ideker T., Network-based classification of breast cancer metastasis. Molecular Systems Biology 2007 3, article 140 2-s2.0-35348891430 10.1038/msb4100180 (Pubitemid 47587026)
27. Taylor I. W., Linding R., Warde-Farley D., Liu Y., Pesquita C., Faria D., Bull S., Pawson T., Morris Q., Wrana J. L., Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nature Biotechnology 2009 27 2 199 204 2-s2.0-59849125136 10.1038/nbt.1522
28. Breitkreutz D., Hlatky L., Rietman E., Tuszynski J. A., Molecular signaling network complexity is correlated with cancer patient survivability. Proceedings of the National Academy of Sciences 2012 109 23 9209 9212
29. Chuang H. Y., Rassenti L., Salcedo M., Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression. Blood 2012 120 13 2639 2649
30. Huang T., Wang J., Cai Y.-D., Yu H., Chou K.-C., Hepatitis c virus network based classification of hepatocellular cirrhosis and carcinoma. PLoS ONE 2012 7 4 2-s2.0-84859499974 10.1371/journal.pone.0034460 e34460
31. Andersen J. N., Sathyanarayanan S., Di Bacco A., Chi A., Zhang T., Chen A. H., Dolinski B., Kraus M., Roberts B., Arthur W., Klinghoffer R. A., Gargano D., Li X., Feldman I., Lynch B., Rush J., Hendrickson R. C., Blume-Jensen P., Paweletz C. P., Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors. Science Translational Medicine 2010 2 43 43ra55 2-s2.0-77955648969 10.1126/scitranslmed. 3001065
32. Carro M. S., Lim W. K., Alvarez M. J., Bollo R. J., Zhao X., Snyder E. Y., Sulman E. P., Anne S. L., Doetsch F., Colman H., Lasorella A., Aldape K., Califano A., Iavarone A., The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010 463 7279 318 325 2-s2.0-75149195336 10.1038/nature08712
33. Bromberg K. D., Ma'ayan A., Neves S. R., Iyengar R., Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth. Science 2008 320 5878 903 909 2-s2.0-44249113841 10.1126/science.1152662 (Pubitemid 351929582)
34. Saez-Rodriguez J., Alexopoulos L. G., Zhang M. S., Morris M. K., Lauffenburger D. A., Sorger P. K., Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Research 2011 71 16 5400 5411 2-s2.0-80051692878 10.1158/0008-5472.CAN-10-4453
35. Rozenblatt-Rosen O., Deo R. C., Padi M., Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 2012 487 491 495
36. Zhang B., Gaiteri C., Bodea L. G., Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 2013 153 3 707 720
37. Stites E. C., Trampont P. C., Ma Z., Ravichandran K. S., Network analysis of oncogenic Ras activation in cancer. Science 2007 318 5849 463 467 2-s2.0-35348988164 10.1126/science.1144642 (Pubitemid 47614534)
38. Klinke D. J. II, Signal transduction networks in cancer: quantitative parameters influence network topology. Cancer Research 2010 70 5 1773 1782 2-s2.0-77950223515 10.1158/0008-5472.CAN-09-3234
39. Liu B., Zhang J., Tan P. Y., Hsu D., Blom A. M., Leong B., Sethi S., Ho B., Ding J. L., Thiagarajan P. S., A computational and experimental study of the regulatory mechanisms of the complement system. PLoS Computational Biology 2011 7 1 2-s2.0-79551555770 10.1371/journal.pcbi.1001059 e1001059
40. Pujana M. A., Han J.-D. J., Starita L. M., Stevens K. N., Tewari M., Ahn J. S., Rennert G., Moreno V., Kirchhoff T., Gold B., Assmann V., Elshamy W. M., Rual J.-F., Levine D., Rozek L. S., Gelman R. S., Gunsalus K. C., Greenberg R. A., Sobhian B., Bertin N., Venkatesan K., Ayivi-Guedehoussou N., Solé X., Hernández P., Lázaro C., Nathanson K. L., Weber B. L., Cusick M. E., Hill D. E., Offit K., Livingston D. M., Gruber S. B., Parvin J. D., Vidal M., Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature Genetics 2007 39 11 1338 1349 2-s2.0-35349024501 10.1038/ng.2007.2 (Pubitemid 350035000)
41. Mani K. M., Lefebvre C., Wang K., Lim W. K., Basso K., Dalla-Favera R., Califano A., A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Molecular Systems Biology 2008 4, article 169 2-s2.0-39149143293 10.1038/msb.2008.2 (Pubitemid 351253195)
42. Wu X., Jiang R., Zhang M. Q., Li S., Network-based global inference of human disease genes. Molecular Systems Biology 2008 4, article 189 2-s2.0-43249114206 10.1038/msb.2008.27 (Pubitemid 351655223)
43. Vanunu O., Magger O., Ruppin E., Shlomi T., Sharan R., Associating genes and protein complexes with disease via network propagation. PLoS Computational Biology 2010 6 1 2-s2.0-76749134818 10.1371/journal.pcbi.1000641 1000641
44. Zhao S., Iyengar R., Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annual Review of Pharmacology and Toxicology 2012 52 505 521 2-s2.0-84855906454 10.1146/annurev-pharmtox-010611- 134520
45. Yildirim M. A., Goh K.-I., Cusick M. E., Barabási A.-L., Vidal M., Drug-target network. Nature Biotechnology 2007 25 10 1119 1126 (Pubitemid 47538114)
46. Paolini G. V., Shapland R. H. B., Van Hoorn W. P., Mason J. S., Hopkins A. L., Global mapping of pharmacological space. Nature Biotechnology 2006 24 7 805 815 2-s2.0-33746156959 10.1038/nbt1228 (Pubitemid 44086621)
47. Hopkins A. L., Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 2008 4 11 682 690 2-s2.0-54249155522 10.1038/nchembio.118
48. Keiser M. J., Roth B. L., Armbruster B. N., Ernsberger P., Irwin J. J., Shoichet B. K., Relating protein pharmacology by ligand chemistry. Nature Biotechnology 2007 25 2 197 206 2-s2.0-33846876695 10.1038/nbt1284 (Pubitemid 46227119)
49. Li J., Zhu X., Chen J. Y., Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology 2009 5 7 2-s2.0-68249111344 10.1371/journal.pcbi.1000450 e1000450
50. Keiser M. J., Setola V., Irwin J. J., Laggner C., Abbas A. I., Hufeisen S. J., Jensen N. H., Kuijer M. B., Matos R. C., Tran T. B., Whaley R., Glennon R. A., Hert J., Thomas K. L. H., Edwards D. D., Shoichet B. K., Roth B. L., Predicting new molecular targets for known drugs. Nature 2009 462 7270 175 181 2-s2.0-70449634957 10.1038/nature08506
51. Campillos M., Kuhn M., Gavin A.-C., Jensen L. J., Bork P., Drug target identification using side-effect similarity. Science 2008 321 5886 263 266 2-s2.0-47249146126 10.1126/science.1158140 (Pubitemid 351989100)
52. Takarabe M., Kotera M., Nishimura Y., Goto S., Yamanishi Y., Drug target prediction using adverse event report systems: a pharmacogenomic approach. Bioinformatics 2012 28 18 i611 i618
53. Cheng F., Liu C., Jiang J., Lu W., Li W., Liu G., Zhou W., Huang J., Tang Y., Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Computational Biology 2012 8 5 e1002503
54. Lounkine E., Keiser M. J., Whitebread S., Mikhailov D., Hamon J., Jenkins J. L., Lavan P., Weber E., Doak A. K., Cote S., Shoichet B. K., Urban L., Large-scale prediction and testing of drug activity on side-effect targets. Nature 2012 486 7403 361 367
55. Kuhn M., Al Banchaabouchi M., Campillos M., Systematic identification of proteins that elicit drug side effects. Molecular Systems Biology 2013 9 663
56. Yang L., Chen J., He L., Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome. PLoS Computational Biology 2009 5 7 2-s2.0-68249128647 10.1371/journal.pcbi.1000441 e1000441
57. Yang L., Wang K., Chen J., Jegga A. G., Luo H., Shi L., Wan C., Guo X., Qin S., He G., Feng G., He L., Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome-clozapine-induced agranulocytosis as a case study. PLoS Computational Biology 2011 7 3 2-s2.0-79953669856 10.1371/journal.pcbi.1002016 e1002016
58. Chang R. L., Xie L., Xie L., Bourne P. E., Palsson B. Ø., Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Computational Biology 2010 6 9 2-s2.0-78049445175 10.1371/journal.pcbi.1000938 e1000938
59. Chen L., Lu J., Zhang J., Feng K.-R., Zheng M.-Y., Cai Y.-D., Predicting chemical toxicity effects based on chemical-chemical interactions. PLoS ONE 2013 8 2 e56517
60. Iorio F., Bosotti R., Scacheri E., Belcastro V., Mithbaokar P., Ferriero R., Murino L., Tagliaferri R., Brunetti-Pierri N., Isacchi A., Di Bernardo D., Discovery of drug mode of action and drug repositioning from transcriptional responses. Proceedings of the National Academy of Sciences of the United States of America 2010 107 33 14621 14626 2-s2.0-77957044703 10.1073/pnas.1000138107
61. Gottlieb A., Stein G. Y., Ruppin E., Sharan R., PREDICT: a method for inferring novel drug indications with application to personalized medicine. Molecular Systems Biology 2011 7, article 496 2-s2.0-79958754253 10.1038/msb.2011.26
62. Sirota M., Dudley J. T., Kim J., Chiang A. P., Morgan A. A., Sweet-Cordero A., Sage J., Butte A. J., Discovery and preclinical validation of drug indications using compendia of public gene expression data. Science Translational Medicine 2011 3 96 96ra77
63. Jin G., Fu C., Zhao H., Cui K., Chang J., Wong S. T. C., A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Research 2012 72 1 33 44 2-s2.0-84855381399 10.1158/0008-5472.CAN-11-2333
64. Iskar M., Zeller G., Blattmann P., Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding. Molecular Systems Biology 2013 9 662
65. Jia J., Zhu F., Ma X., Cao Z. W., Li Y. X., Chen Y. Z., Mechanisms of drug combinations: interaction and network perspectives. Nature Reviews Drug Discovery 2009 8 2 111 128 2-s2.0-59349083179 10.1038/nrd2683
66. Fitzgerald J. B., Schoeberl B., Nielsen U. B., Sorger P. K., Systems biology and combination therapy in the quest for clinical efficacy. Nature Chemical Biology 2006 2 9 458 466 2-s2.0-33747620519 10.1038/nchembio817 (Pubitemid 44266307)
67. Iadevaia S., Lu Y., Morales F. C., Mills G. B., Ram P. T., Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. Cancer Research 2010 70 17 6704 6714 2-s2.0-77956274693 10.1158/0008-5472.CAN-10-0460
68. Zou J., Luo S.-D., Wei Y.-Q., Yang S.-Y., Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry. Molecular BioSystems 2011 7 1 169 179 2-s2.0-78650086757 10.1039/c0mb00004c
69. Zou J., Ji P., Zhao Y.-L., Neighbor communities in drug combination networks characterize synergistic effect. Molecular BioSystems 2012 8 12 3185 3196
70. Lehár J., Krueger A. S., Avery W., Heilbut A. M., Johansen L. M., Price E. R., Rickles R. J., Short G. F. III, Staunton J. E., Jin X., Lee M. S., Zimmermann G. R., Borisy A. A., Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nature Biotechnology 2009 7 659 666
71. Kwong L. N., Costello J. C., Liu H., Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Nature Medicine 2012 18 10 1503 1510
72. Lee M. J., Ye A. S., Gardino A. K., Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012 149 4 780 794